ロード中...
Eculizumab: A Review in Generalized Myasthenia Gravis
The humanized monoclonal antibody eculizumab (Soliris(®)) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with symptoms that are difficult to control with...
保存先:
| 出版年: | Drugs |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845078/ https://ncbi.nlm.nih.gov/pubmed/29435915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-0875-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|